Impact of obesity on catheter ablation of ventricular tachycardia: In‐hospital and 30‐day outcomes

BACKGROUND: Evidence on the impact of obesity on catheter ablation for ventricular tachycardia (VT) is scarce. METHOD AND RESULTS: We queried the Nationwide Readmissions Database to determine the hospital outcomes and procedural complications of VT ablation among the obese and nonobese populations....

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Min Choon, Yeo, Yong Hao, Ang, Qi Xuan, Tan, Bryan E‐Xin, Rattanawong, Pattara, Tan, Jian Liang, Lee, Justin Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407173/
https://www.ncbi.nlm.nih.gov/pubmed/37560290
http://dx.doi.org/10.1002/joa3.12892
Descripción
Sumario:BACKGROUND: Evidence on the impact of obesity on catheter ablation for ventricular tachycardia (VT) is scarce. METHOD AND RESULTS: We queried the Nationwide Readmissions Database to determine the hospital outcomes and procedural complications of VT ablation among the obese and nonobese populations. Obesity was associated with a more prolonged length of stay (p < .01), higher cost of hospitalization (p < .01), and higher rates of pericardial effusion or hemopericardium (p = .05) and vascular complications (p = .05). There was no significant difference in early mortality, 30‐day readmissions, and other procedural complications. CONCLUSION: VT ablation could be performed relatively safely among patients with obesity.

Ejemplares similares